跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FYCOMPA perampanel (as hemisesquihydrate) 2 mg film coated tablet blister - TGA Drug Approval Details
Approvals
/
TGA
/
FYCOMPA perampanel (as hemisesquihydrate) 2 mg film coated tablet blister
Approved
STANDARD
FYCOMPA perampanel (as hemisesquihydrate) 2 mg film coated tablet blister
Eisai Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
f2ec249cd40ce015
Company
Eisai Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
f2ec249cd40ce015
Product Name
FYCOMPA perampanel (as hemisesquihydrate) 2 mg film coated tablet blister
Artg Id
207690
Artg Name
FYCOMPA perampanel (as hemisesquihydrate) 2 mg film coated tablet blister
Sponsor
Eisai Australia Pty Ltd
Company Detail Path
/organization/eisai-australia-pty-ltd
Artg Date
2014-05-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b220651ea908dcc04416cb2f97176b2b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3829f909b7e089dc55600162e3cc3b8b.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
f2ec249cd40ce015
Type
Standard
Back to TGA Approvals